Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,884 | 6,166 | 8,983 | 13,097 | 18,244 |
| TOTAL | $8,050 | $6,588 | $9,587 | $13,653 | $18,723 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 314 | 314 | 1,018 | 1,067 | 1,092 |
| TOTAL | $314 | $314 | $1,018 | $1,067 | $1,092 |
| Total Assets | $8,364 | $6,901 | $10,605 | $14,720 | $19,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 258 | 284 | 241 | 287 | 363 |
| Accrued Expenses | 710 | 611 | 569 | 786 | 1,059 |
| TOTAL | $968 | $894 | $810 | $1,073 | $1,421 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $968 | $894 | $810 | $1,073 | $1,421 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,291 | 1,542 | 1,541 | 1,517 | 1,344 |
| Common Shares | 2 | 2 | 2 | 2 | 14 |
| Retained earnings | -199,875 | -197,195 | -193,234 | -189,100 | -182,547 |
| Other shareholders' equity | -28 | -27 | -27 | -28 | -27 |
| TOTAL | $7,396 | $6,007 | $9,796 | $13,647 | $18,394 |
| Total Liabilities And Equity | $8,364 | $6,902 | $10,605 | $14,720 | $19,815 |